Cargando…

RUNX1 contributes to the mesenchymal subtype of glioblastoma in a TGFβ pathway-dependent manner

Runt-Related Transcription Factor 1 (RUNX1) is highly expressed in the Mesenchymal (Mes) subtype of glioblastoma (GBM). However, the specific molecular mechanism of RUNX1 in Mes GBM remains largely elusive. In this study, cell and tumor tissue typing were performed by RNA-sequencing. Co-immunoprecip...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhao, Kai, Cui, Xiaoteng, Wang, Qixue, Fang, Chuan, Tan, Yanli, Wang, Yunfei, Yi, Kaikai, Yang, Chao, You, Hua, Shang, Rui, Wang, Jiachong, Kang, Chunsheng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6872557/ https://www.ncbi.nlm.nih.gov/pubmed/31754093 http://dx.doi.org/10.1038/s41419-019-2108-x

Ejemplares similares

Mesenchymal glioblastoma constitutes a major ceRNA signature in the TGF-β pathway
por: Wang, Qixue, et al.
Publicado: (2018)

Expert opinion on translational research for advanced glioblastoma treatment
por: Cui, Xiaoteng, et al.
Publicado: (2023)

PTRF/Cavin-1 as a Novel RNA-Binding Protein Expedites the NF-κB/PD-L1 Axis by Stabilizing lncRNA NEAT1, Contributing to Tumorigenesis and Immune Evasion in Glioblastoma
por: Yi, Kaikai, et al.
Publicado: (2022)

Editorial: The State-of-Art in Immuno-Oncology, What to Do With Glioblastoma?
por: Cui, Xiaoteng, et al.
Publicado: (2021)

TCA-phospholipid-glycolysis targeted triple therapy effectively suppresses ATP production and tumor growth in glioblastoma
por: Yang, Shixue, et al.
Publicado: (2022)

TGFβ signaling-induced miRNA participates in autophagic regulation by targeting PRAS40 in mesenchymal subtype of glioblastoma
por: Xie, Yingbin, et al.
Publicado: (2020)

Genomic landscapes by multiregion sequencing combined with circulation tumor DNA detection contribute to molecular diagnosis in glioblastomas
por: Yang, Chao, et al.
Publicado: (2019)

Blockage of EGFR/AKT and mevalonate pathways synergize the antitumor effect of temozolomide by reprogramming energy metabolism in glioblastoma
por: Cui, Xiaoteng, et al.
Publicado: (2023)

Single-Cell Transcriptomics of Glioblastoma Reveals a Unique Tumor Microenvironment and Potential Immunotherapeutic Target Against Tumor-Associated Macrophage
por: Cui, Xiaoteng, et al.
Publicado: (2021)

LncRNA PRADX-mediated recruitment of PRC2/DDX5 complex suppresses UBXN1 expression and activates NF-κB activity, promoting tumorigenesis
por: Li, Yansheng, et al.
Publicado: (2021)

PTRF/Cavin-1 enhances chemo-resistance and promotes temozolomide efflux through extracellular vesicles in glioblastoma
por: Yang, Eryan, et al.
Publicado: (2022)

lncRNA PRADX is a Mesenchymal Glioblastoma Biomarker for Cellular Metabolism Targeted Therapy
por: Xu, Can, et al.
Publicado: (2022)

Single-cell RNA-seq reveals RAD51AP1 as a potent mediator of EGFRvIII in human glioblastomas
por: Wang, Qixue, et al.
Publicado: (2019)

Identification of the E2F1-RAD51AP1 axis as a key factor in MGMT-methylated GBM TMZ resistance
por: Zhou, Junhu, et al.
Publicado: (2023)

Genome‐Wide CRISPR‐Cas9 Screening Identifies NF‐κB/E2F6 Responsible for EGFRvIII‐Associated Temozolomide Resistance in Glioblastoma
por: Huang, Kai, et al.
Publicado: (2019)

RUNX1-ETO (RUNX1-RUNX1T1) induces myeloid leukemia in mice in an age-dependent manner
por: Abdallah, Mohamed Gaber, et al.
Publicado: (2021)

Long non-coding RNA HOTAIR promotes glioblastoma cell cycle progression in an EZH2 dependent manner
por: Zhang, Kailiang, et al.
Publicado: (2014)

Crispr Library Screening: Genome‐Wide CRISPR‐Cas9 Screening Identifies NF‐κB/E2F6 Responsible for EGFRvIII‐Associated Temozolomide Resistance in Glioblastoma (Adv. Sci. 17/2019)
por: Huang, Kai, et al.
Publicado: (2019)

USP10 deubiquitinates RUNX1 and promotes proneural-to-mesenchymal transition in glioblastoma
por: Qiu, Wenjin, et al.
Publicado: (2023)

Rapid design and development of CRISPR-Cas13a targeting SARS-CoV-2 spike protein
por: Wang, Lin, et al.
Publicado: (2021)

Collateral Effects: The CRISPR‐Cas13a Gene‐Editing System Induces Collateral Cleavage of RNA in Glioma Cells (Adv. Sci. 20/2019)
por: Wang, Qixue, et al.
Publicado: (2019)

The CRISPR‐Cas13a Gene‐Editing System Induces Collateral Cleavage of RNA in Glioma Cells
por: Wang, Qixue, et al.
Publicado: (2019)

EGFR-vIII downregulated H2AZK4/7AC though the PI3K/AKT-HDAC2 axis to regulate cell cycle progression
por: Zhao, Hongyu, et al.
Publicado: (2020)

Homotrimer cavin1 interacts with caveolin1 to facilitate tumor growth and activate microglia through extracellular vesicles in glioma
por: Wang, Lin, et al.
Publicado: (2020)

FUNDC1-dependent mitophagy induced by tPA protects neurons against cerebral ischemia-reperfusion injury
por: Cai, Ying, et al.
Publicado: (2020)

RUNX3 inhibits the invasion and migration of esophageal squamous cell carcinoma by reversing the epithelial-mesenchymal transition through TGF-β/Smad signaling
por: Xiao, Zhaohua, et al.
Publicado: (2020)

Truncated forms of RUNX3 Unlike Full Length Protein Alter Cell Proliferation in a TGF-β Context Dependent Manner
por: Rahmanian, Narges, et al.
Publicado: (2017)

A Compound AC1Q3QWB Selectively Disrupts HOTAIR-Mediated Recruitment of PRC2 and Enhances Cancer Therapy of DZNep
por: Li, Yansheng, et al.
Publicado: (2019)

HOXA13 is a potential GBM diagnostic marker and promotes glioma invasion by activating the Wnt and TGF-β pathways
por: Duan, Ran, et al.
Publicado: (2015)

Neuronal STAT3/HIF-1α/PTRF axis-mediated bioenergetic disturbance exacerbates cerebral ischemia-reperfusion injury via PLA2G4A
por: Jin, Weili, et al.
Publicado: (2022)

Engineering blood exosomes for tumor-targeting efficient gene/chemo combination therapy
por: Zhan, Qi, et al.
Publicado: (2020)

Ethanol promotes alcohol-related colorectal cancer metastasis via the TGF-β/RUNX3/Snail axis by inducing TGF-β1 upregulation and RUNX3 cytoplasmic mislocalization
por: Zheng, Kehong, et al.
Publicado: (2019)

HOTAIR Up-Regulation Activates NF-κB to Induce Immunoescape in Gliomas
por: Wang, Yunfei, et al.
Publicado: (2021)

TGFβ signaling directs serrated adenomas to the mesenchymal colorectal cancer subtype
por: Fessler, Evelyn, et al.
Publicado: (2016)

Putting Proteomics Into Immunotherapy for Glioblastoma
por: Chen, Liangyu, et al.
Publicado: (2021)

Novel insight of N(6)-methyladenosine modified subtypes in abdominal aortic aneurysm
por: Wang, Kangjie, et al.
Publicado: (2022)

UBE2C induces EMT through Wnt/β-catenin and PI3K/Akt signaling pathways by regulating phosphorylation levels of Aurora-A
por: Wang, Rui, et al.
Publicado: (2017)

IGFBP3 induced by the TGF-β/EGFRvIII transactivation contributes to the malignant phenotype of glioblastoma
por: Zhang, Xuehua, et al.
Publicado: (2023)

RUNX3 loss turns on the dark side of TGF-beta signaling
por: Krishnan, Vaidehi, et al.
Publicado: (2017)

Hic-5 regulates epithelial to mesenchymal transition in ovarian cancer cells in a TGFβ1-independent manner
por: Sheta, Razan, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_l23bhcrk0an7rge8be18eo7vs0